Leishmania infection: Laboratory diagnosing in the absence of a "gold standard"

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 2, 2010, Pages 251-256

  Rodríguez Cortés, Alhelí ^a   Ojeda, Ana ^a   Francino, Olga ^a   López Fuertes, Laura ^b   Timón, Marcos ^c   Alberola, Jordi ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Toxicology Consultants   (Spain)

^c Agencia Espanola del Medicamento   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; IMMUNOGLOBULIN; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FEMALE; GOLD STANDARD; IMMUNOASSAY; LABORATORY TEST; LEISHMANIASIS; LYMPHOCYTE PROLIFERATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VALIDITY; ANIMAL; BLOOD; BONE MARROW; CELL PROLIFERATION; DOG; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; LEISHMANIA; LYMPHOCYTE; METHODOLOGY; PARASITOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIBODIES, PROTOZOAN; BONE MARROW; CELL PROLIFERATION; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOGLOBULINS; LEISHMANIA; LEISHMANIASIS; LYMPHOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 77449130886     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0366     Document Type: Article

References (39)

1. World Health Organization, 2002. Annex 3: Burden of Disease in DALYs by Cause, Sex and Mortality Stratum in WHO Regions, Estimates for 2001. The World Health Report. Geneva: WHO, 192-197.
2. Mauricio IL, Stothard JR, Miles MA, 2000. The strange case of Leishmania chagasi. Parasitol Today 16: 188-189.
3. Moreno J, Alvar J, 2002. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 18: 399-405.
4. Dantas-Torres F, 2007. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet Parasitol 149: 139-146.
5. Gavgani AS, Mohite H, Edrissian GH, Mohebali M, Davies CR, 2002. Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum. Am J Trop Med Hyg 67: 511-515.
6. Dye C, Killick-Kendrick R, Vitutia MM, Walton R, Killick-Kendrick M, Harith AE, Guy MW, Canavate MC, Hasibeder G, 1992. Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta. Parasitology 105: 35-41.
7. Schnur LF, Jacobson RL, 1987. Appendix III. Parasitological techniques. Peters W, Killick-Kendrick M, eds. The Leishmaniases in Biology and Medicine. New York: Academic Press, 499-542.
8. Solano-Gallego L, Morell P, Arboix M, Alberola J, Ferrer L, 2001. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol 39: 560-563.
9. Cabral M, O'Grady J, Alexander J, 1992. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol 14: 531-539.
10. Cardoso L, Neto F, Sousa JC, Rodrigues M, Cabral M, 1998. Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet Parasitol 79: 213-220.
11. Ashford DA, Bozza M, Freire M, Miranda JC, Sherlock I, Eulalio C, Lopes U, Fernandes O, Degrave W, Barker RH Jr, Badaro R, David JR, 1995. Comparison of the polymerase chain reaction and serology for the detection of canine visceral leishmaniasis. Am J Trop Med Hyg 53: 251-255.
12. Mathis A, Deplazes P, 1995. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J Clin Microbiol 33: 1145-1149.
13. Reale S, Maxia L, Vitale F, Glorioso NS, Caracappa S, Vesco G, 1999. Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood. J Clin Microbiol 37: 2931-2935.
14. Berrahal F, Mary C, Roze M, Berenger A, Escoffier K, Lamouroux D, Dunan S, 1996. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am J Trop Med Hyg 55: 273-277.
15. Valladares JE, Riera C, Alberola J, Gallego M, Portus M, Cristofol C, Franquelo C, Arboix M, 1998. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet Parasitol 75: 33-40.
16. Rodriguez-Cortes A, Ojeda A, Lopez-Fuertes L, Timon M, Altet L, Solano-Gallego L, Sanchez-Robert E, Francino O, Alberola J, 2007. A long term experimental study of canine visceral leishmaniasis. Int J Parasitol 37: 683-693.
17. Reed SG, Shreffler WG, Burns JM Jr, Scott JM, Orge Mda G, Ghalib HW, Siddig M, Badaro R, 1990. An improved serodiagnostic procedure for visceral leishmaniasis. Am J Trop Med Hyg 43: 632-639.
18. Riera C, Valladares JE, Gallego M, Aisa MJ, Castillejo S, Fisa R, Ribas N, Carrio J, Alberola J, Arboix M, 1999. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet Parasitol 84: 33-47.
19. Solano-Gallego L, Riera C, Roura X, Iniesta L, Gallego M, Valladares JE, Fisa R, Castillejo S, Alberola J, Ferrer L, Arboix M, Portus M, 2001. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Vet Parasitol 96: 265-276.
20. Rodriguez A, Solano-Gallego L, Ojeda A, Quintana J, Riera C, Gallego M, Portus M, Alberola J, 2006. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J Vet Intern Med 20: 495-498.
21. Peng ZK, Simons FE, Becker AB, 1991. Differential binding properties of protein A and protein G for dog immunoglobulins. J Immunol Methods 145: 255-258.
22. Barajas-Rojas JA, Riemann HP, Franti CE, 1993. Notes about determining the cut-off value in enzyme linked immunosorbent assay (ELISA). Prev Vet Med 15: 231-233.
23. Bray RS, 1985. Immunodiagnosis of leishmaniasis. Chang KP, Bray RS, eds. Leishmaniasis. Amsterdam: Elsevier Science Publishers.
24. Alberola J, Rodriguez A, Francino O, Roura X, Rivas L, Andreu D, 2004. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. Antimicrob Agents Chemother 48: 641-643.
25. Francino O, Altet L, Sanchez-Robert E, Rodriguez A, Solano-Gallego L, Alberola J, Ferrer L, Sanchez A, Roura X, 2006. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet Parasitol 137: 214-221.
26. Livak KJ, Schmittgen TD, 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Method 25: 402-408.
27. Böyum A, 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21: 77-89.
28. Newcombe NG, 1998. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857-872.
29. Deeks JJ, Altman DG, 1999. Sensitivity and specificity and their confidence intervals cannot exceed 100%. BMJ 318: 193-194.
30. Simel DL, Samsa GP, Matchar DB, 1991. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44: 763-770.
31. Benjamini Y, Hochberg Y, 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc, B 57: 289-300.
32. Jaeschke R, Guyatt G, Sacked DL, 1994. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271: 389-391.
33. Christenson RH, 2007. Evidence-based laboratory medicine - a guide for critical evaluation of in vitro laboratory testing. Ann Clin Biochem 44: 111-130.
34. Fischer JE, Bachmann LM, Jaeschke R, 2003. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 29: 1043-1051.
35. Feinstein AR, 1975. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther 17: 104-116.
36. Fagan TJ, 1975. Letter: nomogram for Bayes theorem. N Engl J Med 293: 257.
37. Deeks JJ, Altman DG, 2004. Diagnostic tests 4: likelihood ratios. BMJ 329: 168-169.
38. Maia C, Campino L, Methods for diagnosis of canine leishmaniasis and immune response to infection. Vet Parasitol 158: 274-287.
39. Rodriguez-Cortes A, Fernandez-Bellon H, Ramis A, Ferrer L, Alberola J, Solano-Gallego L, 2007. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. Vet Immunol Immunopathol 116: 190-198.